Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Marinus PharmaceuticalsSierra OncologyGalectin TherapeuticsCELYAD SA/ADRIDEAYA Biosciences
SymbolNASDAQ:MRNSNASDAQ:SRRANASDAQ:GALTNASDAQ:CYADNASDAQ:IDYA
Price Information
Current Price$1.81$10.27$1.92$8.07$4.23
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$5.14$1.20$9.00$27.33$18.00
% Upside from Price Target183.98% upside-88.32% downside368.75% upside238.70% upside325.53% upside
Trade Information
Market Cap$148.91 million$106.76 million$109.50 million$112.51 million$86.06 million
Beta2.71.152.921.36N/A
Average Volume1,346,08332,764263,40715,78960,857
Sales & Book Value
Annual RevenueN/AN/AN/A$10,000.00N/A
Price / SalesN/AN/AN/A11,249.58N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.72 per share$8.93 per share$0.76 per share$3.67 per share$4.94 per share
Price / BookN/AN/AN/A2.20N/A
Profitability
Net Income$-54,120,000.00$-88,280,000.00$-13,290,000.00$-32,070,000.00$-41,970,000.00
EPS($0.99)($19.52)($0.39)($2.57)($3.36)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-109.35%-76.01%-40.92%N/AN/A
Return on Assets (ROA)-79.82%-56.31%-36.94%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.07%0.06%
Current Ratio11.72%2.32%17.09%3.59%14.65%
Quick Ratio11.72%2.32%17.10%3.59%14.65%
Ownership Information
Institutional Ownership Percentage68.18%N/A17.59%7.84%51.16%
Insider Ownership Percentage2.40%67.68%40.70%N/AN/A
Miscellaneous
Employees28796N/A56
Shares Outstanding82.27 million10.40 million57.03 million13.94 million20.34 million
Next Earnings Date5/6/2020 (Estimated)5/13/2020 (Estimated)5/8/2020 (Estimated)N/A6/23/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel